Back
Kymera Therapeutics Vs. Ally Financial Industry Stock Comparison
Buy
73
KYMR
Kymera Therapeutics
Last Price:
50.95
Seasonality Move:
64.33%
Buy
72
ALLY
Ally Financial
Last Price:
37.57
Seasonality Move:
13.27%
Buy
73
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.86. The Score for KYMR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Ally Financial (ALLY)
is a Buy
Is Ally Financial a Buy, Sell or Hold?
- The current Ally Financial [ALLY] share price is $38.02. The Score for ALLY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
ALLY Stock Price Chart
What is Ally Financial's stock price today?
-
The Ally Financial share price today is $38.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.61 | Buy |
Relative Strength Index (14 RSI): | 59.89 | Buy |
Chaikin Money Flow: | 27367 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.16 - 48.8) | Buy |
Bollinger Bands (100): | (37.72 - 49.44) | Buy |
ALLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 64.81 | Buy |
Chaikin Money Flow: | 2546275 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.34 - 36.18) | Buy |
Bollinger Bands (100): | (35.09 - 42.29) | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.87 | Buy |
20-day SMA: | 47.35 | Buy |
50-day SMA: | 47.05 | Buy |
200-day SMA: | 40.15 | Buy |
8-day EMA: | 48.28 | Buy |
20-day EMA: | 47.57 | Buy |
50-day EMA: | 46.45 | Buy |
200-day EMA: | 39.81 | Buy |
ALLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.77 | Buy |
20-day SMA: | 35.33 | Buy |
50-day SMA: | 35.85 | Buy |
200-day SMA: | 38.41 | Sell |
8-day EMA: | 36.12 | Buy |
20-day EMA: | 35.57 | Buy |
50-day EMA: | 36.28 | Buy |
200-day EMA: | 36.87 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
Ally Financial Earnings Growth & ALLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $1.46 per share.
Kymera Therapeutics Technical Analysis
Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ally Financial Technical Analysis
Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |